Dexcom Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Dexcom Inc 公司

DexCom, Inc. 是一家医疗设备公司。该公司主要专注于设计、开发和商业化连续血糖监测 (CGM)，该系统用于患者、护理人员和临床医生管理糖尿病和代谢健康。其产品包括 Dexcom G6、Dexcom G7、Stelo、Dexcom Share 和 Dexcom ONE。该公司通过创新的生物传感技术让人们掌控健康。Dexcom G6 是其集成的连续血糖监测系统 (iCGM)。Stelo 是专为不使用胰岛素的 II 型糖尿病患者设计的，是美国第一款非处方葡萄糖生物传感器。Dexcom Share 远程监控系统可与任何 Dexcom 系统一起使用，使用患者兼容移动设备上的应用程序。其 Dexcom G7 适用于患有 I 型或 II 型糖尿病的成人和儿童（2 岁以上），他们正在使用任何胰岛素或药物，有低血糖风险，以及患有妊娠糖尿病。

公司简介

公司代码DXCM

公司名称Dexcom Inc

上市日期Apr 14, 2005

成立日期1999

CEOMr. Kevin R. Sayer

员工数量10300

证券类型Ordinary Share

年结日Apr 14

公司地址6340 Sequence Dr

城市SAN DIEGO

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编92121

电话18582000200

网址https://www.dexcom.com/

公司代码DXCM

上市日期Apr 14, 2005

成立日期1999

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Jacob Steven (Jake) Leach

President, Chief Operating Officer

276.26K

+6.52%

Mr. Kevin R. Sayer

Chairman of the Board, Chief Executive Officer

233.94K

+11.70%

Mr. Mark G. Foletta

Lead Independent Director

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

40.15K

+34.41%

Ms. Bridgette P. Heller

Independent Director

28.04K

+21.94%

Mr. Kyle Malady

Independent Director

23.33K

+28.62%

Ms. Renee D. Gala

Independent Director

10.79K

+88.71%

名称

名称/职务

职务

持股

持股变动

Mr. Jacob Steven (Jake) Leach

President, Chief Operating Officer

276.26K

+6.52%

Mr. Kevin R. Sayer

Chairman of the Board, Chief Executive Officer

233.94K

+11.70%

Mr. Mark G. Foletta

Lead Independent Director

62.13K

+4.65%

Mr. Steven R. (Steve) Altman

Independent Director

61.05K

+4.13%

Mr. Richard Alexander Collins

Independent Director

44.38K

+5.82%

Mr. Nicholas (Nick) Augustinos

Independent Director

42.13K

+6.12%

收入明细

单位: USD更新时间: 4月6日周日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Distributor

3.43B

85.05%

Direct

602.90M

14.95%

地区USD

名称

营收

占比

United States

2.89B

71.65%

Outside of United states

1.14B

28.35%

业务

地区

业务USD

名称

营收

占比

Distributor

3.43B

85.05%

Direct

602.90M

14.95%

股东统计

更新时间: 5月20日周二

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

12.06%

BlackRock Institutional Trust Company, N.A.

6.30%

State Street Global Advisors (US)

4.25%

Baillie Gifford & Co.

3.62%

Capital Research Global Investors

3.07%

Other

70.69%

持股股东

占比

The Vanguard Group, Inc.

12.06%

BlackRock Institutional Trust Company, N.A.

6.30%

State Street Global Advisors (US)

4.25%

Baillie Gifford & Co.

3.62%

Capital Research Global Investors

3.07%

Other

70.69%

股东类型

持股股东

占比

Investment Advisor

44.97%

Investment Advisor/Hedge Fund

38.84%

Hedge Fund

3.80%

Research Firm

3.75%

Bank and Trust

2.04%

Pension Fund

2.03%

Sovereign Wealth Fund

1.41%

Individual Investor

0.40%

Venture Capital

0.37%

Other

2.39%

机构持股

更新时间: 1月19日周日

报告期

机构数

持股数

持股占比

持股变动

2025Q1

2209

389.23M

99.27%

-25.73M

2024Q4

2220

380.88M

97.47%

-26.96M

2024Q3

2145

382.31M

97.83%

-30.58M

2024Q2

2115

397.02M

99.11%

-4.31M

2024Q1

2093

389.18M

98.33%

-19.87M

2023Q4

2081

398.01M

103.26%

+83.33K

2023Q3

1994

389.89M

100.89%

-11.88M

2023Q2

1952

389.17M

100.78%

-12.73M

2023Q1

1908

390.83M

100.84%

-11.09M

2022Q4

1889

389.49M

100.81%

-14.66M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

46.36M

11.82%

-900.98K

-1.91%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

24.18M

6.17%

+3.21K

+0.01%

Dec 31, 2024

State Street Global Advisors (US)

16.69M

4.26%

+19.76K

+0.12%

Dec 31, 2024

Baillie Gifford & Co.

14.61M

3.73%

-404.87K

-2.70%

Dec 31, 2024

Capital Research Global Investors

14.37M

3.67%

-3.58M

-19.93%

Dec 31, 2024

Jennison Associates LLC

7.64M

1.95%

+710.86K

+10.25%

Dec 31, 2024

Sands Capital Management, LLC

11.11M

2.83%

+790.30K

+7.66%

Dec 31, 2024

Geode Capital Management, L.L.C.

9.99M

2.55%

+56.09K

+0.56%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

8.08M

2.06%

+108.41K

+1.36%

Feb 28, 2025

Nuveen LLC

7.82M

2%

+61.83K

+0.80%

Dec 31, 2024

持股ETF

更新时间: 6月6日周五

机构名称

占比

Langar Global HealthTech ETF

9.85%

First Trust Nasdaq Lux Digi Health Solutions ETF

7.09%

Global X Internet of Things ETF

6.94%

Fidelity Digital Health ETF

5.08%

Global X HealthTech ETF

4.47%

Touchstone Sands Capital US Select Growth ETF

4.33%

Harbor Health Care ETF

4.22%

iShares U.S. Medical Devices ETF

4.04%

Motley Fool Mid-Cap Growth ETF

3.71%

Motley Fool Global Opportunities ETF

2.93%

Langar Global HealthTech ETF

占比9.85%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比7.09%

Global X Internet of Things ETF

占比6.94%

Fidelity Digital Health ETF

占比5.08%

Global X HealthTech ETF

占比4.47%

Touchstone Sands Capital US Select Growth ETF

占比4.33%

Harbor Health Care ETF

占比4.22%

iShares U.S. Medical Devices ETF

占比4.04%

Motley Fool Mid-Cap Growth ETF

占比3.71%

Motley Fool Global Opportunities ETF

占比2.93%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

Mar 28, 2022

Split

1>4

公告日期

类型

比率

Mar 28, 2022

Split

1>4

Dexcom Inc

79.840USD

Dexcom Inc

79.840

概览

公司